Limited data are currently available on the causality of NSF; however, case reports and retrospective studies have demonstrated a strong association with the administration of gadolinium-based contrast agents [GBCAs] in renally-compromised patients, with the development of NSF.

«« Leading European Society Announces Collaboration with EMC Consulting for New Healthcare Journal


Hologic to Acquire Third Wave Technologies »»


Latest Articles

Limited data are currently available on the causality of NSF; however, case reports and retrospective studies have demonstrated a strong association with...